The use of fluoroquinolones for companion animal antimicrobial therapy.
about
Oral Bioavailability and Plasma Disposition of Pefloxacin in Healthy Broiler Chickens.Disposition kinetics of levofloxacin in sheep after intravenous and intramuscular administrationPharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducksDisposition Kinetic of Moxifloxacin following Intravenous, Intramuscular, and Subcutaneous Administration in Goats.Effects of oral orbifloxacin on fecal coliforms in healthy cats: a pilot studySusceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.Comparative Pharmacokinetics of Levofloxacin in Healthy and Renal Damaged Muscovy Ducks following Intravenous and Oral AdministrationInfluence of flunixin on the disposition kinetic of cefepime in goats.Mutant prevention concentration of orbifloxacin: comparison between Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus pseudintermedius of canine origin.Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administrationPharmacokinetics of difloxacin in olive flounder Paralichthys olivaceus at two water temperatures.Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens.Pharmacokinetics of ibafloxacin following intravenous and oral administration to healthy Beagle dogs.Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis.Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys.Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin after intravenous and intramuscular administration in beagle dogs.Pharmacokinetics of levofloxacin in Japanese quails (Coturnix japonica) following intravenous and oral administration.Use of quercetin in animal feed: effects on the P-gp expression and pharmacokinetics of orally administrated enrofloxacin in chicken.Bacteraemia in 66 cats and antimicrobial susceptibility of the isolates (1995–2004)
P2860
Q33720333-DB806EBE-13AC-413A-A26E-11D925FFCE57Q34271413-60F92D6C-E932-479D-93FA-8A28CACFB774Q36276123-9866F182-54CE-4B60-BD61-DD0E59B35724Q36858028-369B85CA-7D8E-4FF2-AA38-D3F2897C5155Q38373004-BDD00978-D4EF-479D-B526-633EAA85C375Q38427273-A1E3F84C-C775-4205-B37C-2B3DFAA24AABQ38581416-08A400A1-FEB8-493D-95A4-0DA4F2EB11A2Q39763534-FE1D3C58-E20D-4360-A296-87C48BF669ECQ40478739-0885F56C-69F4-4A4E-AEBE-836F428EEBF9Q41917434-795B7CF5-C683-4D7A-8B45-D52EB5FBED75Q42602439-EC6A16A3-D89C-4100-B895-2B2181EFA6F0Q42675855-C964B551-04DF-4B59-9F48-B51ED70269B1Q43986548-7D55A1E8-910A-49DD-BE56-ADCD77BFB1BFQ44126238-45FADA73-03E1-480B-99AF-86B3349D6ED2Q46340114-7C8C1923-38B7-42DD-B0BE-E7DB33BE91D0Q53247094-3EF1C0EA-9859-442D-ABB7-63DDC2587DAEQ54317332-2006929C-E0EF-4739-AA0F-3A018916484FQ55089033-BEBB868C-5B47-4F4B-A8F1-72D060AFAE0CQ58206883-1119DAAD-AFCF-4EA6-90D2-419D5691BB0A
P2860
The use of fluoroquinolones for companion animal antimicrobial therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The use of fluoroquinolones for companion animal antimicrobial therapy.
@ast
The use of fluoroquinolones for companion animal antimicrobial therapy.
@en
type
label
The use of fluoroquinolones for companion animal antimicrobial therapy.
@ast
The use of fluoroquinolones for companion animal antimicrobial therapy.
@en
prefLabel
The use of fluoroquinolones for companion animal antimicrobial therapy.
@ast
The use of fluoroquinolones for companion animal antimicrobial therapy.
@en
P2860
P1476
The use of fluoroquinolones for companion animal antimicrobial therapy.
@en
P2093
P2860
P356
10.1111/J.1751-0813.2000.TB10528.X
P577
2000-02-01T00:00:00Z